WEBINAR SERIES
Benefits Curve | How to Plan for GLP-1 Medications in 2025 and Beyond
August 2024
Learn about employee benefits business risks – and how to get ahead of the curve – with key insights and actionable takeaways from our team. Stay tuned for fresh topics every other month!
Are you concerned about covering GLP-1 drugs on your employee benefits plan?
Employers struggle with rising healthcare costs, and GLP-1 medications are a significant contributor. These powerful drugs for patients with diabetes and obesity come at a price tag exceeding $10,000 per patient annually. But there is hope!
Discover how to optimize the use of GLP-1s in your pharmacy program.
Our panel of seasoned pharmacists – Laura Matarazzo, RPh, Vice President, Middle Market Plan Sponsor Consulting, and Sarah Fleming, PharmD, Senior Pharmacy Benefit Clinical Consultant – was moderated by Morgan Lee, PhD, MPH, CPH, Senior Director, Research & Strategy at PSG.
What We Covered:
- When GLP-1s are the right choice: Learn how to distinguish between situations where GLP-1s are most beneficial or lower-cost alternatives are effective for diabetes treatment.
- Strategies for smart utilization: Discover practical utilization management techniques to ensure the right patients get GLP-1s for the intended diagnoses. We also cover how to optimize coverage for patients with obesity.
- The future of GLP-1s: Gain insights into the upcoming pipeline and studies of expanded indications. We explore how these trends might impact costs in the coming years.
View the recording
Sign up for Benefits Curve Employer Risk Event Notifications
You’ll receive invitations to our upcoming webinars covering timely employee benefits risk topics, with actionable takeaways.
